https://solasta-ventures.com/team daily 0.75 2026-01-08 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577789412464-OYKLDREE962DWU4X4ZEM/image.jpg Team https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577789699178-91O1WT2D1HDPLT7OXMDB/image-asset.jpeg Team https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/f15aae30-3179-49d9-b2e3-e5d4fb0969c0/Derek+5.jpg Team - Derek Yoon President & CEO https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/fa0ccc83-b5a1-400e-9690-afaa23b96be2/Katlyn+Gabriel.jpg Team - Katlyn Gabriel Associate https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/4ec01cb2-e7f1-4eac-bd05-47908ae5668d/Nia+5.jpg Team - Nia Julian Executive Assistant https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1578406942058-4JA1FPNRR0B7J0P9E4RM/Michael_Jeon-1.jpg Team - Michael Jeon Managing Partner https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1578332546939-WYG71X3T4N3VSIUIFB2Y/william_hahn_sog_4033_15.jpg Team - William C. Hahn, M.D., Ph.D. Scientific Advisory Board https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1658855975930-R8G7WDME5GNZ61VHG3X4/Byoung+Chul+Cho+Headshot.jpg Team - Byoung Chul Cho, M.D., Ph.D. Byoung Chul Cho, M.D, Ph.D. Scientific Advisory Board https://solasta-ventures.com/news daily 0.75 2026-03-31 https://solasta-ventures.com/news/2026/3/31/biogen-to-buy-apellis-pharmaceuticals-for-56-billion-in-rare-disease-push monthly 0.5 2026-03-31 https://solasta-ventures.com/news/2026/3/9/rallybio-to-acquire-candid-therapeutics monthly 0.5 2026-03-09 https://solasta-ventures.com/news/2026/2/24/gilead-to-buy-arcellx-in-78b-wager-on-multiple-myeloma-cell-therapy monthly 0.5 2026-02-24 https://solasta-ventures.com/news/2026/1/20/gsk-pays-22b-to-buy-rapt-for-its-phase-2-stage-food-allergy-challenger-to-xolair monthly 0.5 2026-01-20 https://solasta-ventures.com/news/2025/5/22/ensoma-announces-fda-clearance-of-ind-application-for-first-in-vivo-hsc-directed-gene-insertion-therapy monthly 0.5 2025-05-22 https://solasta-ventures.com/news/2025/3/17/lilly-backed-uk-biotech-raises-72m-to-advance-its-antibody-approach monthly 0.5 2025-03-17 https://solasta-ventures.com/news/2025/2/13/abbvie-signs-heavily-backloaded-21b-xilio-biobucks-pact-in-big-pharmas-latest-t-cell-engager-deal monthly 0.5 2025-02-13 https://solasta-ventures.com/news/2024/11/19/recode-therapeutics-announces-additional-funding-from-the-cystic-fibrosis-foundation monthly 0.5 2024-11-19 https://solasta-ventures.com/news/2024/10/31/abbvie-and-evolveimmune-therapeutics-announce-collaboration-and-option-to-license-agreement-to-develop-next-generation-cancer-biotherapeutics monthly 0.5 2024-10-31 https://solasta-ventures.com/news/2024/10/30/axonis-therapeutics-announces-115-million-series-a-financing monthly 0.5 2024-10-30 https://solasta-ventures.com/news/2024/2/15/intellia-therapeutics-and-recode-therapeutics-announce-strategic-collaboration-to-develop-novel-gene-editing-therapies-for-cystic-fibrosis monthly 0.5 2024-02-15 https://solasta-ventures.com/news/2023/12/21/immunotherapy-biotech-raises-37m-from-backers-like-pfizer-takeda-bms monthly 0.5 2024-01-03 https://solasta-ventures.com/news/2023/11/15/arcellx-and-kite-announce-expansion-in-strategic-partnership-1 monthly 0.5 2023-11-15 https://solasta-ventures.com/news/2023/9/20/recode-raises-260m-in-series-b-financing-to-advance-lead-programs monthly 0.5 2023-09-20 https://solasta-ventures.com/news/2023/3/8/carisma-therapeutics-closes-merger-with-sesen-bio monthly 0.5 2023-03-08 https://solasta-ventures.com/news/2023/1/5/ensoma-announces-85-million-financing-and-agreement-to-acquire-twelve-bio-to-advance-portfolio-of-in-vivo-engineered-cellular-medicines monthly 0.5 2023-01-05 https://solasta-ventures.com/news/2022/12/12/kite-and-arcellx-announce-strategic-collaboration-to-co-develop-and-co-commercialize-late-stage-clinical-cart-ddbcma-in-multiple-myeloma monthly 0.5 2022-12-12 https://solasta-ventures.com/news/2022/12/6/abbvie-launches-strategic-collaboration-with-hotspot-therapeutics-to-further-expand-immunology-pipeline monthly 0.5 2022-12-06 https://solasta-ventures.com/news/2022/9/30/trefoil-therapeutics-announces-positive-tthx1114-phase-2-study-data monthly 0.5 2022-09-30 https://solasta-ventures.com/news/2022/9/21/immunitas-therapeutics-receives-fda-clearance-of-ind-application-for-imt-009-in-solid-tumors-and-hematological-malignancies monthly 0.5 2022-09-21 https://solasta-ventures.com/news/2022/9/21/sesen-bio-and-carisma-therapeutics-announce-merger-agreement monthly 0.5 2022-09-21 https://solasta-ventures.com/news/2022/6/29/kezars-phase-2-lupus-data-spur-hope-for-former-pipeline-in-a-drug-contenderand-a-share-rally monthly 0.5 2022-06-29 https://solasta-ventures.com/news/2022/6/21/carbon-biosciences-emerges-with-a-new-viral-vector-to-shake-up-the-cystic-fibrosis-gene-therapy-field monthly 0.5 2022-06-21 https://solasta-ventures.com/news/2022/6/9/asco-any-way-you-slice-it-arcellxs-car-t-is-matching-jampj-legends-carvykti-analyst-says monthly 0.5 2022-06-09 https://solasta-ventures.com/news/2022/2/8/arcellx-raises-124m-in-wall-street-debut-to-bankroll-study-of-multiple-myeloma-car-t monthly 0.5 2022-02-08 https://solasta-ventures.com/news/2022/1/11/moderna-and-carisma-establish-collaboration-to-develop-in-vivo-engineered-chimeric-antigen-receptor-monocytes-car-m-for-oncology monthly 0.5 2022-01-11 https://solasta-ventures.com/news/2021/10/27/swizfm92i1jttrplwhromf6rpp3odi monthly 0.5 2021-10-27 https://solasta-ventures.com/news/2021/10/25/xilio-therapeutics-announces-pricing-of-initial-public-offering monthly 0.5 2021-10-25 https://solasta-ventures.com/news/2021/10/6/0qlqwe9kqny99m9oovanlbezhl0hrd monthly 0.5 2021-10-06 https://solasta-ventures.com/news/2021/8/20/sutro-biopharma-announces-stro-002-fda-fast-track-designation-for-patients-with-advanced-ovarian-cancer monthly 0.5 2021-08-20 https://solasta-ventures.com/news/2021/8/18/immunitas-therapeutics-completes-58-million-series-b-financing-to-advance-pipeline monthly 0.5 2021-08-18 https://solasta-ventures.com/news/2021/7/27/arvinas-and-pfizer-announce-global-collaboration-to-develop-and-commercialize-protac-protein-degrader-arv-471 monthly 0.5 2021-07-27 https://solasta-ventures.com/news/2021/7/12/rallybio-hits-high-gear-as-it-targets-100m-ipo-to-fund-treatments-for-rare-fetal-bleeding-disorder monthly 0.5 2021-07-12 https://solasta-ventures.com/news/2021/7/6/rallybio-announces-clinical-proof-of-concept-for-rlyb211-an-anti-hpa-1a-antibody-for-the-prevention-of-fetal-and-neonatal-alloimmune-thrombocytopenia-fnait monthly 0.5 2021-07-06 https://solasta-ventures.com/news/2021/6/30/ateas-at-527-an-oral-antiviral-drug-candidate-reduces-viral-replication-in-hospitalized-patients-with-covid-19-in-phase-2-interim-analysis monthly 0.5 2021-06-30 https://solasta-ventures.com/news/2021/6/28/kymera-therapeutics-announces-positive-interim-results-from-single-ascending-dose-phase-1-trial-of-kt-474-demonstrating-degrader-proof-of-mechanism monthly 0.5 2021-06-28 https://solasta-ventures.com/news/2021/6/17/xilio-therapeutics-announces-fda-acceptance-of-ind-application-for-xtx101-for-the-treatment-of-solid-tumors monthly 0.5 2021-06-17 https://solasta-ventures.com/news/2021/6/15/clearside-biomedical-announces-positive-safety-results-from-cohort-1-of-oasis-phase-12a-clinical-trial monthly 0.5 2021-06-15 https://solasta-ventures.com/news/2021/6/14/rapt-therapeutics-reports-positive-topline-results-from-phase-1b-trial monthly 0.5 2021-06-14 https://solasta-ventures.com/news/2021/4/7/arcellx-announces-fda-clearance-of-ind-application-for-aclx-001-a-controllable-cell-therapy-utilizing-the-companys-arc-sparx-platform-for-the-treatment-of-multiple-myeloma monthly 0.5 2021-04-07 https://solasta-ventures.com/news/2021/2/15/fda-approves-g1-therapeutics-cosela-to-prevent-chemo-damage-in-lung-cancer monthly 0.5 2021-02-15 https://solasta-ventures.com/news/2021/2/11/molecular-templates-establishes-multi-target-collaboration-with-bristol-myers-squibb-for-the-discovery-and-development-of-next-generation-engineered-toxin-bodies-for-the-treatment-of-cancer monthly 0.5 2021-02-11 https://solasta-ventures.com/news/2021/1/25/carisma-therapeutics-completes-series-b-funding-for-47-million-to-advance-development-of-novel-car-macrophage-immunotherapies monthly 0.5 2021-01-25 https://solasta-ventures.com/news/2020/12/8/redwood-city-based-seers-stock-nearly-tripled-in-ipo-valuing-company-at-over-3b monthly 0.5 2020-12-08 https://solasta-ventures.com/news/2020/11/16/apellis-announces-fda-acceptance-and-priority-review-of-the-new-drug-application-for-pegcetacoplan-for-the-treatment-of-pnh monthly 0.5 2020-11-16 https://solasta-ventures.com/news/2020/10/22/saoqz95vfnq0m432w2nbi81gv9bxhx monthly 0.5 2020-10-22 https://solasta-ventures.com/news/2020/9/28/atea-pharmaceuticals-fierce-15-2020-winner monthly 0.5 2020-09-28 https://solasta-ventures.com/news/2020/12/8/kymera-raising-173m-becomes-the-48th-biotech-ipo-of-the-year-as-2020-surpasses-2019 monthly 0.5 2020-12-08 https://solasta-ventures.com/news/2020/5/21/hotspot-therapeutics-completes-65-million-series-b-financing-to-advance-pipeline-of-novel-allosteric-medicines monthly 0.5 2020-05-21 https://solasta-ventures.com/news/2020/5/20/atea-pharmaceuticals-announces-ind-clearance-of-at-527-for-covid-19-and-215-million-financing monthly 0.5 2020-05-20 https://solasta-ventures.com/news/2020/5/19/0dt2pk2517gb0az6r43c19da8xtg97 monthly 0.5 2020-05-19 https://solasta-ventures.com/news/https/wwwbiospacecom/article/releases/orionis-biosciences-debuts-with-major-pharmaceutical-collaboration-to-tackle-industry-s-most-challenging-protein-targets monthly 0.5 2020-03-09 https://solasta-ventures.com/news/2020/3/3/akrevia-therapeutics-rebrands-as-xilio-therapeutics-and-announces-1005-million-series-b-financing monthly 0.5 2020-03-03 https://solasta-ventures.com/news/amphivena-closes-62-million-series-c-financing-to-expand-the-clinical-development-of-amv564-into-solid-tumors-and-to-develop-its-t-cell-engagement-portfolio monthly 0.5 2019-12-30 https://solasta-ventures.com/news/vertex-and-molecular-templates-establish-collaboration-to-discover-and-develop-novel-targeted-conditioning-regimens-to-enhance-hematopoietic-stem-cell-transplants monthly 0.5 2019-12-19 https://solasta-ventures.com/news/kezar-announces-promising-new-data-with-kzr-616-at-the-american-college-of-rheumatology-annual-meeting monthly 0.5 2019-12-19 https://solasta-ventures.com/news/kymera-therapeutics-to-present-preclinical-data-on-its-first-in-class-irak4-degraders-demonstrating-robust-inhibition-of-inflammatory-responses-and-superiority-to-irak4-kinase-inhibitors monthly 0.5 2019-12-19 https://solasta-ventures.com/news/bellicum-pharmaceuticals-presents-encouraging-preclinical-data-for-gocar-nk-cell-program-at-society-for-immunotherapy-of-cancer-annual-meeting monthly 0.5 2019-12-19 https://solasta-ventures.com/news/apellis-presents-positive-first-data-on-apl-2-in-c3-glomerulopathy-at-asn-kidney-week-nov-8-2019 monthly 0.5 2019-12-19 https://solasta-ventures.com/news/arvinas-presents-a-platform-update-including-initial-data-from-the-first-two-clinical-trials-of-protac-targeted-protein-degraders monthly 0.5 2019-12-19 https://solasta-ventures.com/news/arcellx-raises-85-million-in-a-series-b-financing-to-advance-its-intelligent-cell-therapy-platform monthly 0.5 2019-12-19 https://solasta-ventures.com/news/g1-therapeutics-presents-first-clinical-data-on-oral-serd-g1t48-demonstrating-safety-and-tolerability-in-patients-with-advanced-breast-cancer-at-esmo-2019 monthly 0.5 2019-12-31 https://solasta-ventures.com/home daily 1.0 2024-08-20 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1576592287026-I44UY16YIDSNNEJA1XEG/image-asset.jpeg Home https://images.squarespace-cdn.com/content/v1/57bf309d46c3c410fdf9cc34/1472491155320-3AVT4RKJCVZ2Y7D5XACQ/Aro+Ha_1183.jpg Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577789412464-OYKLDREE962DWU4X4ZEM/image.jpg Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1723042113530-ZMNPBCZBZX3L6I53ZJ7X/Business+Group+1.jpg Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1576750700837-CP3JBE9ZOUQ6WN1RGLG1/Amphivena.png Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607610472641-SNK2CS8ZXK4UDXI8F0RO/Apellis+non-Nasdaq.png Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1677252191926-Y8A51LV0BFARSY615P83/Arcellx.jpg Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607610609718-CE2VQJCBN6D9TOFWV5GB/Arvinas.png Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1730296688249-PTP7022TB62RXZW35BK2/Axonis.jpg Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607610534477-Q426JIBJV0MQOQCB6PQJ/G1+Therapeutics.png Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1677252276767-EJ5XU1XZ7923VOFQUVDT/Hotspot.png Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577786705295-DRIVZ35ADISYQ0EH33BO/Kymera.jpg Home https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577706323520-HD660FG0EQHNPWCZNK34/image.jpg Home - Investing in a brighter future. We are committed to investing in innovative companies that advance the standard of care for diseases with unmet medical needs. Our team leverages deep scientific expertise and an extensive network to identify promising therapeutics and discovery platforms that have the potential to transform patients’ lives worldwide. https://solasta-ventures.com/portfolio daily 0.75 2020-01-24 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577714492932-6931R0QNYKTXFRN7FCW9/image-asset.jpeg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577789412464-OYKLDREE962DWU4X4ZEM/image.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1573747864552-NVFA585B2R62BEBTKAUS/Amphivena.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607439819112-NPTET4T307KL8FEWOSRV/Apellis+non-Nasdaq.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1677252073338-WKB9V61DCUTDMDLXXC3X/Arcellx.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607440354911-GUZZPK4YHYOU8MLOQ9TC/Arvinas.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1573747959652-8P3W8VG185EYD3K8X1WR/ATEA.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1730296502906-V6410FOQ2ES81P3R7PN1/Axonis.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607440826657-ENVGQVLM1C4D9XIMA7GH/Bellicum.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1655819455737-QN48A4A3NE2P33QC1HB5/Carbon+Biosciences.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1609780846377-VKJHH17D9CA6I45LP6OT/Carisma.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1578335874364-01GAZ9EXIX5BZGCSDFMN/Chameleon.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1623768819870-ETDEB1YUT7YZLH9925WM/Clearside+Bio.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1672940304857-5XJ8CC6PI7TKIY1PBQ0E/Ensoma.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1603130403158-XD6LYIFGW55QHUN0W9Y7/Evolveimmune+Thera.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607441003994-BD5AFKUGG4C30P24BVPZ/G1+Therapeutics.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1677252121968-EJ7A26E1H74NLCO7RCCX/Hotspot.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1629295846782-1RTK09H50ZWTWQBPL6WI/immunitas_updated_Logo.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607441111180-T1E0M4SX02N7CV6EU7SF/Kezar+Life+Science.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1573748018787-CRKC4EG5NDI3X7HVSDH9/Kymera.JPG Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1742303531201-B41SOR9HGH8DIA1L9TPF/Maxion+png.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607441226245-80ZJHRAEZPODF3HS4SK1/Molecular+Templates.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1583774779883-HGWN47PUY5HTLQSY554D/Orionis+Bio+Logo.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1589900032342-25ZEH4A0AYIJ9H6PC049/Rallybio.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607441295494-NQEFH5ZCQADJAMQ4P5VG/RAPT.jpg Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1695220860506-3CQ6072LO34DND9J1SXL/Recode+Tx.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1597253262087-9R0ISCODM7A9G3Q46ZGQ/Seer+PNG.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607441369313-H1JQDQJX7VBD5JGRRYPA/Selecta.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607441413591-2E4D7DW81XKQX721TDA9/Sutro.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1607441462103-BXQJM0K8JJ1DKVYVJIVT/Synlogic.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1573748084214-IFV3G4CUOPQOI9VBYKXS/Trefoil.png Portfolio https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1583265256351-08TO8KDAF8O30I73H41G/Xilio+new+logo.jpg Portfolio https://solasta-ventures.com/our-approach daily 0.75 2024-08-20 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577785372073-GRN0T9K5XPS9IAU2P3AX/image-asset.jpeg Approach https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1723042241819-4QM0VPTE6QCRX6QIKHXD/Casual+Group+1.jpg Approach https://solasta-ventures.com/contact daily 0.75 2024-09-03 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1577707749168-J7EL0KEB79S69U3ULOKK/image-asset.jpeg Contact https://solasta-ventures.com/hatchery daily 0.75 2024-09-03 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1639693470701-PYPZR7YV61M33H48Q4GB/unsplash-image-J1rNS2qv8BQ.jpg Hatchery https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1639763771973-UOUEW80O51650SKLWUJ4/unsplash-image-K3m7ZpqHfks.jpg Hatchery https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/ff1fcc69-870d-42a0-a9b1-65fea65e7d01/SHatch_Logo_Orange.png Hatchery - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://solasta-ventures.com/under-construction daily 0.75 2019-11-18 https://solasta-ventures.com/derek-yoon daily 0.75 2024-08-12 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/3ed44105-b255-4d6a-bf8c-9ff45c0e9087/Derek+5.jpg Derek Yoon https://solasta-ventures.com/katlyn-gabriel daily 0.75 2026-01-09 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/15986033-aeea-4941-9dfe-05f2f0e2307d/Katlyn+Gabriel.jpg Katlyn Gabriel https://solasta-ventures.com/nia-julian daily 0.75 2024-08-12 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/8203aef6-5873-4ba2-a913-95d347e13aa5/Nia+5.jpg Nia Julian https://solasta-ventures.com/william-c-hahn daily 0.75 2020-01-06 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1578338757221-XIDS01CS2MN1QDWQBK82/william_hahn_sog_4033_15.jpg William C. Hahn https://solasta-ventures.com/michael-jeon daily 0.75 2020-01-07 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1578389156217-E738QRKTSY9457JF2LP4/Michael_Jeon.jpg Michael Jeon https://solasta-ventures.com/hatchery-main-1 daily 0.75 2021-12-16 https://solasta-ventures.com/byoungchulcho daily 0.75 2022-07-26 https://images.squarespace-cdn.com/content/v1/5acbb1eeb98a78beef1a922c/1658856972007-B0A9V3EF2OVOLUA34GMI/Byoung+Chul+Cho+Headshot.jpg Byoung Chul Cho https://solasta-ventures.com/request-moksha daily 0.75 2025-05-09 https://images.squarespace-cdn.com/content/v1/57bf309d46c3c410fdf9cc34/1487777772741-P50TXT95V4Z8ZIV2RZOZ/Aro-Ha_0348.jpg Request